英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
|
739366-20-2 |
阿拉格列汀
|
SUINY;SK-0403;阿拉格列汀;阿拉格列汀原料药;阿拉格列汀系列杂质;阿拉格列汀杂;阿拉格列汀(盐酸盐);(R)-阿拉格列汀;阿拉格列汀 IM K
|
C19H25N7O2 |
383.4475 | |
Crisaborole
|
906673-24-3 |
AN2728
|
AN2728;AN 2728;AN2728;AN 2728;克洛硼罗;克立硼罗杂质18;CS-1895;4-((1-羟基-1,3-二氢苯并[C][1,2]氧杂硼戊环-5-基)氧)苯甲腈;克瑞沙硼;克立硼罗;AN-2728;AN2728;AN 2728
|
C14H10BNO3 |
251 | |
Amyloid b-Protein (1-15)
|
183745-81-5 |
183745-81-5
|
H-ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-OH;AMyloid b-Protein (1-15);Amyloid beta-Protein (1-15) trifluoroacetate salt;AMYLOID BETA-PROTEIN (1-15)
|
C78H107N25O27 |
1826.85 | |
Amyloid b-Peptide (1-43) (human)
|
134500-80-4 |
淀粉Β-蛋白(1-43)
|
淀粉Β-蛋白(1-43);BETA-淀粉样肽 A4(1-43)
|
C207H318N56O62S1 |
4615.14 | |
Amyloid b-peptide (1-42) (rat)
|
166090-74-0 |
H-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-OH
|
BETA-淀粉样肽(1-42)
|
C203H311N55O60S |
4417.95158 | |
beta-Amyloid (1-42) human
|
107761-42-2 |
大豆肽
|
大豆低聚肽粉;AMYLOID 尾-PEPTIDE (1-42)HUMAN;Β-淀粉样多肽 1-42,≥95% ;Amyloid β Protein Fragment 1-42,人属Aβ42 95%;Β-淀粉样多肽,人属AΒ4;Β-淀粉样蛋白(1-42),人;Β-AMYLOID PEPTIDE (1-42),RAT;Β-淀粉样多肽(1-42)
|
C203H311N55O60S1 |
4514.04 | |
Amyloid b-peptide (1-40) (rat)
|
144409-98-3 |
BETA-淀粉样肽(1-40)
|
BETA-淀粉样肽(1-40);AMYLOID 尾-PEPTIDE (1-40)RAT
|
C190H291N51O57S |
||
Amyloid b-Peptide (10-20) (human)
|
152286-31-2 |
TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE
|
淀粉样β蛋白片段10-20;淀粉样β肽(10-20)(人)
|
C71H99N17O16 |
1446.65 | |
Amrubicin
|
110267-81-7 |
氨柔比星
|
|
C25H25NO9 |
483.47 | |
AMG517
|
659730-32-2 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]氧基]-2-苯并噻唑基]乙酰胺
|
AMG517;AMG-517;N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]氧基]-2-苯并噻唑基]乙酰胺;CS-691
|
C20H13F3N4O2S |
430.41 | |
AMG-47a
|
882663-88-9 |
4-甲基-3-[2-[[2-(4-吗啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺
|
4-甲基-3-[2-[[2-(4-吗啉基)乙基]氨基]-6-喹唑啉基]-N-[3-(三氟甲基)苯基]苯甲酰胺;CS-1025;AMG 47;AMG-47;AMG47;AMG47A;GENETICIN
|
C29H28F3N5O2 |
535.56013 | |
AM679
|
1206880-66-1 |
AM-679
|
AM-679;AM 679;5-[[(2S)-1-乙酰基-2,3-二氢-1H-吲哚-2-基]甲氧基]-3-[叔丁基硫基]-1-[[4-(5-甲氧基-2-嘧啶基)苯基]甲基]-ALPHA,ALPHA-二甲基-1H-吲哚-2-丙酸
|
C20H20INO |
417.28337 | |
AM630
|
164178-33-0 |
[6-碘-2-甲基-1-[2-(4-吗啉基)乙基]-1H-吲哚-3-基](4-甲氧基苯基)甲酮
|
[6-碘-2-甲基-1-[2-(4-吗啉基)乙基]-1H-吲哚-3-基](4-甲氧基苯基)甲酮;(6-碘-2-甲基-1-(2-吗啉-4-基乙基)-1H-吲哚-3-基)(4-甲氧基苯基)甲酮;AM630;AM 630;AM-630;CS-1545;AM630;AM 630
|
C23H25IN2O3 |
504.36 | |
AM095 (Sodium Salt)
|
1345614-59-6 |
4'-[3-甲基-4-[[[(1R)-1-苯基乙氧基]羰基]氨基]-5-异恶唑基]联苯-4-乙酸钠盐
|
AM-095;AM095;AM 095;4'-[3-甲基-4-[[[(1R)-1-苯基乙氧基]羰基]氨基]-5-异恶唑基]联苯-4-乙酸钠盐
|
C27H24N2O5.Na |
478.48 | |
Alvimopan dihydrate
|
170098-38-1 |
爱维莫潘
|
爱维莫潘二水合物;LY 246736 DIHYDRATE;ADL 8-2698 DIHYDRATE
|
C25H36N2O6 |
460.57 | |
Altrenogest
|
850-52-2 |
四烯雌酮
|
烯炳孕素;四烯雌酮,烯丙孕素;四烯雌酮;D9-4-氨基联苯;烯丙基群勃龙;硫酸金刚烷胺;四烯雌酮,丙烯孕酮;阿特伦格斯特杂质
|
C21H26O2 |
310.43 | 212-703-1 |
alpha-Hederin
|
123350-57-2 |
HEDERAGENIN-3-O-Α-L-RHAMNOPYRANOSYL (1→2)-Α-L-ARABINOPYRANOSIDE
|
|
C41H66O12 |
750.95554 | 248-166-5 |
Alosetron hydrochloride
|
122852-69-1 |
盐酸阿洛司琼
|
盐酸阿洛司琼;2,3,4,5-四氢-5-甲基-2-[(5-甲基-1H-咪唑-4-基)甲基]-1H-吡啶并[4,3-b]吲哚-1-酮盐酸盐;盐酸阿洛司琼API;盐酸阿洛司琼 / 2,3-B]吲哚-1-酮盐酸盐;盐酸阿洛司琼122852-69-1;2,5-四氢-5-甲基-2-[(4-甲基-1H-咪唑-5-基)甲基]-1H-吡啶并[4,3-B]吲哚-1-酮盐酸盐
|
C17H18N4O.HCl |
330.81196 | 802-450-0 |
Alogliptin Benzoate
|
850649-62-6 |
苯甲酸阿格列汀
|
2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氢-3-甲基-2,4-二氧代-1(3H)-嘧啶基]甲基]苯甲腈苯甲酸盐;苯甲酸阿格列汀;吡格列酮苯酸酯;阿格列汀苯甲酸盐;苯甲酸阿格利汀;阿格列汀
|
C18H21N5O2.C7H6O2 |
461.519 | 691-730-4 |
alogliptin
|
850649-61-5 |
阿洛利停
|
苯甲酸阿格列汀中间体N-1;阿格列汀(SYR-322);苯甲酸阿格列汀中间体2;苯甲酸阿格列汀原料药;(R)-2-(6-(3-氨基哌啶基)-3-甲基-2,4-二氧杂-3,4-二氢嘧啶-1(2H)-基)甲基)苯腈;阿格列汀,高效选择性DPP-4抑制剂;曲格列汀降解杂质;TRELAGLIPTIN-12
|
C18H21N5O2 |
339.397 | 821-899-3 |